18:57 , Nov 16, 2018 |  BC Week In Review  |  Company News

DeepMind's healthcare team joins Google

The DeepMind Technologies subsidiary of Alphabet Inc. (NASDAQ:GOOG) is merging its health team into Google Inc. following Google's announcement that David Feinberg will be joining the tech company to organize its healthcare efforts. Feinberg is...
18:50 , Nov 16, 2018 |  BC Week In Review  |  Company News

Google Brings Geisinger CEO on Board to Focus on Healthcare

Beyond a quick mention of Verily Life Sciences LLC and AI, Google Inc. is saying little about what it plans to do with its healthcare initiatives now that David Feinberg is leaving Geisinger Health System...
00:39 , Nov 10, 2018 |  BC Extra  |  Company News

Google brings Geisinger CEO on board to focus on healthcare

Beyond a quick mention of Verily Life Sciences LLC and AI, Google Inc. is saying little about what it plans to do with its healthcare initiatives now that David Feinberg is leaving Geisinger Health System...
19:24 , Oct 26, 2018 |  BC Week In Review  |  Company News

Amazon joins NIH's STRIDES Initiative

Amazon Web Services Inc., part of Amazon.com Inc. (NASDAQ:AMZN), has joined NIH's Science and Technology Research Infrastructure for Discovery, Experimentation, and Sustainability (STRIDES) Initiative, which will allow researchers participating in the initiative access to Amazon's...
03:01 , Sep 1, 2018 |  BioCentury  |  Politics, Policy & Law

A pathway to Biopharma 3.0

As market and social forces continue to tighten around the biopharmaceutical industry, drug companies need to start evolving toward a new business model that both capitalizes on the potential of new technologies and accommodates society’s...
21:30 , Jul 24, 2018 |  BC Innovations  |  Translation in Brief

Interaction analysis

In a collaboration with Merck & Co. Inc. (NYSE:MRK) and SomaLogic Inc., University of Cambridge researchers have identified associations and causal relationships between thousands of genetic variants, plasma proteins and disease states, which could reveal...
00:43 , Jun 29, 2018 |  BC Innovations  |  Product R&D

Highly personal

Pact Pharma Inc. has raised $120 million in venture financing to tackle one of the most complex forms of personalized medicine proposed to date: neoantigen-targeted T cells. Backed by Alphabet Inc.’s GV, the company is...
19:06 , May 18, 2018 |  BC Week In Review  |  Company News

BC Platforms, Google Cloud partner to offer genomics solutions

Genomic data management company BC Platforms (Basel, Switzerland) partnered with Google Cloud from Google Inc.'s parent company Alphabet Inc. (NASDAQ:GOOG) to deliver integrated genomics and clinical data solutions via Google's services to hospitals and industry...
23:43 , May 15, 2018 |  BioCentury  |  Finance

Single Celsius

After identifying its first targets, Third Rock Ventures newco Celsius Therapeutics emerged from stealth with a $65 million series A round to apply single-cell genomics techniques to drug development for autoimmune diseases and cancer. GV,...
16:19 , May 4, 2018 |  BC Week In Review  |  Company News

Gilead, Verily seek to uncover immunological insights from Gilead trials

Gilead Sciences Inc. (NASDAQ:GILD) and the Verily Life Sciences LLC (South San Francisco, Calif.) subsidiary of Google parent company Alphabet Inc. (NASDAQ:GOOG) partnered to identify and characterize immunological and molecular drivers of rheumatoid arthritis, inflammatory...